Novel antibiotics in development to treat Clostridium difficile infection

PURPOSE OF REVIEWClostridium difficile infections (CDI) remain a challenge to treat clinically due primarily to limited number of antibiotics available and unacceptably high recurrence rates. Because of this, there has been significant demand for creating innovative therapeutics, which has resulted...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Current opinion in gastroenterology 2017-01, Vol.33 (1), p.1-7
Hauptverfasser:	Bassères, Eugénie, Endres, Bradley T, Dotson, Kierra M, Alam, M Jahangir, Garey, Kevin W
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Benzimidazoles - therapeutic use Benzopyrans - therapeutic use Clinical Trials as Topic Clostridium Infections - drug therapy Depsipeptides - therapeutic use Humans Lipopeptides - therapeutic use Oxazolidinones - therapeutic use Peptides, Cyclic - therapeutic use Pyridines - therapeutic use Thiazoles - therapeutic use Thiophenes - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!